Status:
ENROLLING_BY_INVITATION
Traditional Asian Diet and Gut Microbiome and Metabolome in Healthy Volunteers and Pregnancy on Infant's Allergy Development
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Pregnancy
Food Hypersensitivity
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The research aims to elucidate a specially-designed personalized diet based on Traditional Asian Diet and its efficacy in increasing the gut colonization of Prevotella sp. and butyrate levels in pregn...
Detailed Description
A preliminary pilot study is first will be conducted among a group of healthy volunteers. This pilot study aims to assess the feasibility of the intervention and obtain pre-eliminary data on its effic...
Eligibility Criteria
Inclusion
- Malaysian and of the Malay ethnicity
- Living in Kelantan for at least 5 years
- Age 18 to 40 years
- The lower limit of ≥16th weeks and the upper limit of \<20th week of gestation during enrollment to allow at least 20 weeks of dietary intervention prior to delivery. The gestational age was based on the last menstrual period (LMP) or early ultrasound examination
- Singleton pregnancy
- History of personal and family history of allergy (presence of reported or doctor-diagnosed allergic disease including asthma, eczema, food allergy, or allergy rhinitis) in participants, their partners or in their previous child or pregnancy.
- In attendance of antenatal clinic at Hospital USM or Klinik Kesihatan (Kota Bharu/Kubang Kerian/Pengkalan Chepa)
- Living area within 10 km radius of Kota Bharu, Kelantan
- Consent to participate
Exclusion
- Significant present or having past medical history of chronic disease for example bowel, cancer disease, systemic lupus erythematosus (SLE), chronic kidney disease, heart failure, stroke, haematological malignancy, and chronic obstructive pulmonary disease.
- Significant psychiatric history including major depression and other psychotic disorders.
- Significant present or past surgical history including bowel surgeries
- Significant presence of doctor-diagnosed short intestinal bacteria overgrowth (SIBO).
- Taking any medications which may disturb the gut microbiota or intestinal function, for example, antibiotics for the past 3 months, immunosuppressive drugs, opiates, anticoagulants and etc.
- Those who plan to move out from Kelantan after delivery which may affect the follow-up.
- Those who follow a vegetarian diet will also be excluded from participating.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04885959
Start Date
September 1 2021
End Date
December 30 2025
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universiti Sains Malaysia
Kota Bharu, Kelantan, Malaysia, 16150